Position in TECH
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$4,749,587
+$1,906,894 QoQ
Shares Held
67,227
+31.6% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#163
of 581 holders
Holding Since
Jun 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TECH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WINTON GROUP Ltd holds $97,029,578 across 91 Biotechnology names. TECH ranks #4 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
254,408 | $28,839,690 | |
| 2 | FTRE |
Fortrea Holdings Inc.
|
389,155 | $6,771,297 | |
| 3 | EXEL |
Exelixis, Inc.
|
99,834 | $5,431,967 | |
| 4 | TECH |
BIO-TECHNE Corp
This page
|
67,227 | $4,749,587 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
60,348 | $4,723,437 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
90,546 | $3,532,199 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7,880 | $2,372,116 | |
| 8 | TRVI |
Trevi Therapeutics, Inc.
|
106,852 | $1,992,789 |
All Filings in TECH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,749,587 | 67,227 | Shares | Sole | 2026-08-07 | |
| 2025-09-30 | $2,842,693 | 51,100 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $6,230,286 | 121,094 | Shares | Sole | 2025-08-14 | |
| 2021-09-30 | $1,183,804 | 2,443 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $466,919 | 1,037 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,274,118 | 3,336 | Shares | Sole | 2021-07-21 | |
| 2020-12-31 | $1,623,950 | 5,114 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $3,260,126 | 13,160 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $3,739,231 | 14,160 | Shares | Sole | 2020-08-05 | |
| No filing history on record for this holder in this stock. | ||||||